Tizanidine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68788-7781
  • Package NDC 68788-7781-1
  • Package NDC 68788-7781-2
  • Package NDC 68788-7781-3
  • Package NDC 68788-7781-6
  • Package NDC 68788-7781-8
  • Package NDC 68788-7781-9
  • Application number ANDA076286
  • SPL ID ba5049f2-6370-4cfd-a8f5-d83e6b25bdd9
  • SPL set ID 32c3be66-5398-425c-ac65-e57ba819bb43
  • UNII B53E3NMY5C
  • RxCUI 313413

What the source publishes

Labeler
Preferred Pharmaceuticals, Inc.
Active ingredients
Tizanidine
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68788-7781_ba5049f2-6370-4cfd-a8f5-d83e6b25bdd9
{
  "name": "Tizanidine",
  "splId": "ba5049f2-6370-4cfd-a8f5-d83e6b25bdd9",
  "labels": [
    {
      "setId": "32c3be66-5398-425c-ac65-e57ba819bb43",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32c3be66-5398-425c-ac65-e57ba819bb43",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=32c3be66-5398-425c-ac65-e57ba819bb43"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Preferred Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 TABLET in 1 BOTTLE (68788-7781-1)",
      "package_ndc": "68788-7781-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200901"
    },
    {
      "sample": false,
      "description": "20 TABLET in 1 BOTTLE (68788-7781-2)",
      "package_ndc": "68788-7781-2",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200901"
    },
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (68788-7781-3)",
      "package_ndc": "68788-7781-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200901"
    },
    {
      "sample": false,
      "description": "60 TABLET in 1 BOTTLE (68788-7781-6)",
      "package_ndc": "68788-7781-6",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200901"
    },
    {
      "sample": false,
      "description": "120 TABLET in 1 BOTTLE (68788-7781-8)",
      "package_ndc": "68788-7781-8",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200901"
    },
    {
      "sample": false,
      "description": "90 TABLET in 1 BOTTLE (68788-7781-9)",
      "package_ndc": "68788-7781-9",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20200901"
    }
  ],
  "productId": "68788-7781_ba5049f2-6370-4cfd-a8f5-d83e6b25bdd9",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "68788-7781",
  "deaSchedule": null,
  "genericName": "Tizanidine",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TIZANIDINE HYDROCHLORIDE",
      "strength": "4 mg/1"
    }
  ],
  "applicationNumber": "ANDA076286",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200901",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "B53E3NMY5C"
    ],
    "rxcui": [
      "313413"
    ],
    "spl_set_id": [
      "32c3be66-5398-425c-ac65-e57ba819bb43"
    ],
    "manufacturer_name": [
      "Preferred Pharmaceuticals, Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68788-7781_ba5049f2-6370-4cfd-a8f5-d83e6b25bdd9"